
Hexima
HXL.AXHexima Limited Price (HXL.AX)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
167,039,629
(0)%
Community Sentiment
0 votes
↑ 0%
↓ 0%
Description
Hexima Limited, a biotechnology company, engages in the research and development of plant-derived proteins and peptides for applications as human therapeutics. The company's lead drug candidate is the plant defensin, pezadeftide, which is in phase IIb clinical trials for the treatment of fungal toenail infections in Australia and New Zealand. Hexima Limited was incorporated in 1997 and is based in Preston, Australia. Read More
Sector: Healthcare
- Previous Close Fetching Data...
- Range $0.008-0.021
- Market Cap 2.17M
- Enterprise Value No Data
- Avg Volume Fetching Data...
- P/E Ratio Fetching Data...
- Dividend Yield Fetching Data...
Industry: Biotechnology
- ceo: Mr. Geoffrey Paul Kempler B.Sc.
- IPO Date: November, 30, 2020
- Country: AU
- Currency: AUD
- Headquaters: Preston, VIC
- Employees: No Data
- Revenue from each product or segment:
Product or Segment | Value: | % - Total | Last 3Y: |
---|

- Revenue by Region
Product or Segment | Value: | % - Total | Last 3Y: |
---|
